Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled AsthmaCompleted
NCT02099656Phase 2Updated Sep 6, 2017
Sponsor: Hoffmann-La Roche
Asthma
United States, Canada, France, Ireland, Sweden +1 more
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Completed
NCT02546700Phase 2Updated Sep 6, 2017
Sponsor: Hoffmann-La Roche
Chronic Obstructive Pulmonary Disease
United States, Argentina, Bulgaria, Canada, Denmark +4 more
An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B StudyCompleted
NCT02201407N/AUpdated Aug 31, 2017
Sponsor: Hoffmann-La Roche
Hepatitis B, Chronic
Serbia
Xeloda and Bevacizumab to Treat Rectal CancerCompleted
NCT00847119Phase 2Updated Aug 29, 2017
Sponsor: Institut Català d'Oncologia
Rectal Cancer
Spain
An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast CancerCompleted
NCT01661153N/AUpdated Aug 25, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
Croatia
A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac DiseaseCompleted
NCT02679014Phase 1Updated Aug 25, 2017
Sponsor: Hoffmann-La Roche
Celiac Disease
United Kingdom
Safety Study of PLX4032 in Patients With Solid TumorsCompleted
NCT00405587Phase 1Updated Aug 22, 2017
Sponsor: Plexxikon
Malignant Melanoma · Colorectal Carcinoma
United States, Australia
Big Data Analysis of the Use of bIomarkers ConcentrationCompleted
NCT03254472N/AUpdated Aug 22, 2017
Sponsor: Hospital Avicenne
Biological Markers · Inappropriate Prescribing
France
Impact of Dialysis Modality on Hepcidin and Iron MetabolismCompleted
NCT01723111N/AUpdated Aug 22, 2017
Sponsor: Kyungpook National University Hospital
End-stage Renal Disease
South Korea
A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)Completed
NCT01063062Phase 3Updated Aug 21, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Egypt
A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD TherapyCompleted
NCT02006706Phase 3Updated Aug 21, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Serbia
A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.Completed
NCT00502840Phase 3Updated Aug 18, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Germany
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to ChemotherapyCompleted
NCT02013817Phase 2Updated Aug 18, 2017
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Austria
Paclitaxel and Capecitabine in Treating Women With Metastatic Breast CancerCompleted
NCT00005649Phase 2Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
United States
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 YearsCompleted
NCT01480674N/AUpdated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
France
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTerminated
NCT00099177Phase 3Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Pain · Bone Neoplasm · Neoplasm Metastasis
United States, Argentina, Australia, Chile, Germany +11 more
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTerminated
NCT00099203Phase 3Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Pain · Bone Neoplasm · Neoplasm Metastasis
United States, Argentina, Australia, Belgium, Canada +13 more
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.Withdrawn
NCT00478270Phase 2Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Pain · Bone Neoplasm · Neoplasm Metastasis
Greece
A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.Completed
NCT00502853Phase 4Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Italy
Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)Completed
NCT01326559Phase 2Updated Aug 16, 2017
Sponsor: Hong Kong Nasopharyngeal Cancer Study Group Limited
Nasopharyngeal Carcinoma
China
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNFCompleted
NCT01326962Phase 3Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Saudi Arabia
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompleted
NCT01000610Phase 4Updated Aug 16, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Tunisia
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.Completed
NCT00738374Phase 2Updated Aug 15, 2017
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Italy
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.Completed
NCT00545688Phase 2Updated Aug 15, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
Australia, Austria, Brazil, Canada, Israel +13 more
A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaCompleted
NCT01001299Phase 1Updated Aug 15, 2017
Sponsor: Hoffmann-La Roche
Malignant Melanoma
United States

Previous page Next page